Ronald J. Ellis Jr. Pacira Bio Sciences, Inc. (PCRX) insider trading activity

PCRX Quotes by TradingView

Ronald J. Ellis Jr. is Chief Strategy Officer of Pacira BioSciences, Inc.. Currently has a direct ownership of 30,909 shares of PCRX, which is worth approximately $586,652. The most recent transaction as insider was on Jun 07, 2023, when has been sold 1,162 shares (Common Stock) at a price of $37.87 per share, resulting in proceeds of $44,004. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.9K
0% 3M change
0% 12M change
Total Value Held $586,652

Ronald J. Ellis Jr. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 07 2023
SELL
Open market or private sale
$44,004 $37.87 p/Share
1,162 Reduced 3.62%
30,909 Common Stock
Jun 06 2023
SELL
Open market or private sale
$43,434 $38.99 p/Share
1,114 Reduced 3.36%
32,071 Common Stock
RJE

Ronald J. Ellis Jr.

Chief Strategy Officer
Tampa, FL

Track Institutional and Insider Activities on PCRX

Follow Pacira BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCRX shares.

Notify only if

Insider Trading

Get notified when an Pacira Bio Sciences, Inc. insider buys or sells PCRX shares.

Notify only if

News

Receive news related to Pacira BioSciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCRX